Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”

類似資料

• Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
  著者:: Dan Călugăru, 等
  出版事項: (2017-09-01)
• Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion
  著者:: Wang, Mei-Zi, 等
  出版事項: (2016)
• Comment on “Correlation between macular ganglion cell-inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion”
  著者:: Călugăru, Dan, 等
  出版事項: (2019)
• Comment on “Intravitreal dexamethasone implants for diabetic macular edema”
  著者:: Călugăru, Dan, 等
  出版事項: (2018)
• Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'
  著者:: Călugăru, D, 等
  出版事項: (2016)